Nanoform and Celanese demonstrate enhanced drug delivery through smaller implants
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Bourgoin early development hub broadens offerings for oral solid dose formulations
Subscribe To Our Newsletter & Stay Updated